KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Retained Earnings (2016 - 2026)

Bio-Rad Laboratories has reported Retained Earnings over the past 18 years, most recently at -$235.4 million for Q1 2026.

  • Quarterly Retained Earnings fell 103.15% to -$235.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$235.4 million through Mar 2026, down 103.15% year-over-year, with the annual reading at -$189.1 million for FY2025, 102.55% down from the prior year.
  • Retained Earnings was -$235.4 million for Q1 2026 at Bio-Rad Laboratories, down from -$189.1 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $7.5 billion in Q1 2025 and troughed at -$823.8 million in Q3 2022.
  • The 5-year median for Retained Earnings is -$10.6 million (2022), against an average of $1.6 billion.
  • Year-over-year, Retained Earnings crashed 5899.59% in 2024 and then soared 2465.02% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$10.3 million in 2022, then tumbled by 3162.14% to -$336.0 million in 2023, then surged by 2307.26% to $7.4 billion in 2024, then tumbled by 102.55% to -$189.1 million in 2025, then dropped by 24.48% to -$235.4 million in 2026.
  • Per Business Quant, the three most recent readings for BIO's Retained Earnings are -$235.4 million (Q1 2026), -$189.1 million (Q4 2025), and $7.5 billion (Q3 2025).